source
- Men turn to chatbots for therapy as earnings season unfoldsThe latest STAT Health Tech newsletter notes growing optimism about mental‑health chatbots, especially among men who are less likely to seek traditional therapy. It also recaps key points from the…
- FDA's rare disease framework faces its first real test in Capricor’s DMD drugLast month, the FDA committed to designing a "fit-for-purpose" framework for regulating rare disease therapies based on patient need and realistically attainable evidence. With the upcoming decisio…BioSpace · 54m ago↗ source
- STAT+: GLP-1s are given an FDA warning for rare eye condition risk